返回
Fresenius SE & Co. KGaA (FSNUY) 收益
FSNUY 股價走勢圖
FSNUY 收益
Fresenius SE & Co. KGaA
$12.57
-1.21%
$-0.15
收盤價：Apr 02, 16:00:00 GMT-4
$12.57
0%
$0
盤後：Apr 02, 20:00:00 GMT-4
最新獲利結果： Q4 '25
報導： 2026-02-25
歷史收益
每季
年度
EPS
收入
Earnings FAQ
FSNUY 最近的每股盈餘與預期相比如何？
Fresenius SE & Co. KGaA FSNUY 上一季度的收入表現如何？
Fresenius SE & Co. KGaA 的收入預期是多少？
Fresenius SE & Co. KGaA 的盈利品質評分是多少？
Fresenius SE & Co. KGaA 何時發布財報？
Fresenius SE & Co. KGaA 的預期收益是多少？
Fresenius SE & Co. KGaA 是否超出收益預期？
關鍵數據
前收市價
$12.72
開盤價
$12.47
當日範圍
$12.45 - $12.66
52週區間
$9.78 - $33.93
交易量
24.7K
平均成交量
77.1K
股息收益率
--
每股盈餘 (TTM)
0.59
市值
$28.3B
什麼是 Fresenius SE & Co. KGaA？
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.